Diagnosis typically involves a combination of clinical evaluation, hormonal assays, and genetic testing. Newborn screening programs often detect elevated levels of 17-hydroxyprogesterone, prompting further investigation. Confirmatory tests may include ACTH stimulation tests and genetic analysis of the CYP21A2 gene.
